Literature DB >> 5429180

The effect of MK-185 on some aspects of uric acid metabolism.

A Jain, J R Ryan, D Hague, F G McMahon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5429180     DOI: 10.1002/cpt1970114551

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

1.  Clinical evaluation of MK-185: a new hypolipidemic drug.

Authors:  C Sirtori; A Hurwitz; K Sabih; D Azarnoff
Journal:  Lipids       Date:  1972-02       Impact factor: 1.880

Review 2.  Pharmacology of uricosuric drugs.

Authors:  I Kippen; M W Whitehouse; J R Klinenberg
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

3.  Studies on the mechanism of action of halofenate.

Authors:  L R Mandel
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

4.  Gemcadiol: a new antilipemic drug, a clinical trial.

Authors:  H P Blumethal; J R Ryan; A K Jain; F G McMahon
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.